This study is looking at how well the VA National TeleOncology (NTO) program works for Veterans newly diagnosed with lung, colorectal, prostate, or breast cancer. The NTO program offers medical and specialty cancer care through telehealth (virtual visits) as an alternative to in-person care. Researchers want to see how often Veterans use telehealth visits and if the program helps with the quality of their care and healthcare costs. You might be able to join if you are a Veteran, 18 or older, and have been newly diagnosed with one of these cancers within the last three months. The study aims to enroll 1800 participants. The current recruitment status is unclear.

Study design

This is an interventional study that aims to enroll 1800 participants. It is designed to test the effectiveness of an existing program, not a new drug.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary outcomes, such as the number of telehealth visits, are measured up to 3 months after the National TeleOncology program is put in place.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.